Press Releases

Sign up for Email Alerts Press Release RSS

03/14/2018
Bristol-Myers Squibb to Announce Results for First Quarter 2018 on April 26
Term:Corporate/Financial News
Language:English
03/11/2018
Findings Released from Largest Real-World Data Analysis of Non-Valvular Atrial Fibrillation Patients Receiving Direct Oral Anticoagulants
Term:$BMY
Language:English
03/07/2018
Bristol-Myers Squibb to Take Part in Barclays Global Healthcare Conference
Term:Corporate/Financial News
Language:English
03/06/2018
Bristol-Myers Squibb Named One of the 2018 "Top 70 Companies for Executive Women"
Term:Philanthropy News
Language:English
03/06/2018
Bristol-Myers Squibb’s Opdivo® (nivolumab) Now the First and Only FDA-Approved PD-1 Inhibitor to Offer Every Four-Week Dosing
Term:Corporate/Financial News
Language:English
03/05/2018
Bristol-Myers Squibb to Take Part in Cowen and Company 38th Annual Global Health Care Conference
Term:Corporate/Financial News
Language:English
03/01/2018
Bristol-Myers Squibb Announces Dividend
Term:Corporate/Financial News
Language:English
03/01/2018
Bristol-Myers Squibb Names José Baselga, M.D., Ph.D. to Board of Directors
Term:Corporate/Financial News
Language:English
02/26/2018
Bristol-Myers Squibb Announces Expansion of the International Immuno-Oncology Network (II-ON) with Addition of Yale Cancer Center
Term:R&D News
Language:English
02/14/2018
Bristol-Myers Squibb and Nektar Therapeutics Announce Global Development & Commercialization Collaboration for Nektar’s CD122-biased Agonist, NKTR-214
Term:Partnering News
Language:English

Business Wire NewsHQ^sm